|
|
||||||||||||||
|
|
|||||||||||||||
AIRWAY BIOLOGY |
1 CBR Institute for Biomedical Research Inc, Harvard Medical School, Boston, Massachusetts, USA
2 Department of Pediatrics, University of Colorado School of Medicine and The Childrens Hospital, Denver, Colorado, USA
3 Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA
Correspondence to:
Correspondence to:
Dr E Remold-ODonnell
Center for Blood Research, 800 Huntington Avenue, Boston, MA 02115, USA; remold{at}cbr.med.harvard.edu
Background: In patients with cystic fibrosis (CF) neutrophils are recruited in excess to the airways yet pathogens are not cleared and the patients suffer from chronic infections. Recent studies have shown a deficiency in airway fluids from patients with CF and other inflammatory pulmonary conditions of surfactant protein A (SP-A), a pattern recognition molecule that facilitates uptake of microbes by macrophages and neutrophils.
Methods: In vitro simulations were used to test the hypothesis that decreased SP-A levels in CF might be the result of degradation by neutrophil serine proteases.
Results: Very low levels of the neutrophil granule serine proteases cathepsin G, elastase, and proteinase-3 rapidly degraded pure SP-A when tested in buffered saline. The order of potency was cathepsin G>elastase>proteinase-3. The addition of cathepsin G or elastase to normal bronchoalveolar lavage (BAL) fluid caused a dose dependent degradation of endogenous native SP-A. Cathepsin G and elastase were present in the BAL fluid from many patients with CF. Simple incubation of protease positive BAL fluid from patients with CF caused a time dependent degradation of added SP-A or, where present, endogenous SP-A. The degradation of SP-A by protease(s) in BAL fluid of patients with CF was abrogated by diisopropylfluorophosphate and monocyte/neutrophil elastase inhibitor.
Conclusions: The findings strongly suggest that the neutrophil serine proteases cathepsin G and/or elastase and/or proteinase-3 contribute to degradation of SP-A and thereby diminish innate pulmonary antimicrobial defence.
Keywords: inflammation; neutrophil serine proteases; cathepsin G; surfactant protein A; cystic fibrosis
Abbreviations: BAL, bronchoalveolar lavage; CF, cystic fibrosis; CRD, carbohydrate recognition domain; DFP, diisopropyl fluorophosphate; MeOSuc, methoxysuccinyl; MNEI, monocyte/neutrophil elastase inhibitor; PVDF, polyvinyldine difluoride; SBzl, thiobenzyl ester; SP-A, surfactant protein-A; Suc, succinyl
This article has been cited by other articles:
![]() |
J. Cooley, B. McDonald, F. J. Accurso, E. C. Crouch, and E. Remold-O'Donnell Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease J. Leukoc. Biol., April 1, 2008; 83(4): 946 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. White, T. Tecle, E. C. Crouch, and K. L. Hartshorn Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1293 - L1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. S. Tagaram, G. Wang, T. M. Umstead, A. N. Mikerov, N. J. Thomas, G. R. Graff, J. C. Hess, M. J. Thomassen, M. S. Kavuru, D. S. Phelps, et al. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1052 - L1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yasumatsu, O. Altiok, C. Benarafa, C. Yasumatsu, G. Bingol-Karakoc, E. Remold-O'Donnell, and S. Cataltepe SERPINB1 upregulation is associated with in vivo complex formation with neutrophil elastase and cathepsin G in a baboon model of bronchopulmonary dysplasia Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L619 - L627. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Grubor, D. K. Meyerholz, and M. R. Ackermann Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet. Pathol., September 1, 2006; 43(5): 595 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Starosta, E. Rietschel, K. Paul, U. Baumann, and M. Griese Oxidative Changes of Bronchoalveolar Proteins in Cystic Fibrosis. Chest, February 1, 2006; 129(2): 431 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Lee, R. C. Rancourt, G. del Val, K. Pack, C. Pardee, F. J. Accurso, and C. W. White Thioredoxin and dihydrolipoic acid inhibit elastase activity in cystic fibrosis sputum Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L875 - L882. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Hirche, E. C. Crouch, M. Espinola, T. J. Brokelman, R. P. Mecham, N. DeSilva, J. Cooley, E. Remold-O'Donnell, and A. Belaaouaj Neutrophil Serine Proteinases Inactivate Surfactant Protein D by Cleaving within a Conserved Subregion of the Carbohydrate Recognition Domain J. Biol. Chem., June 25, 2004; 279(26): 27688 - 27698. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |